Some biotech startups are not prioritizing artificial intelligence for drug discovery, according to the focus of STAT’s AI Prognosis newsletter. The newsletter says these companies believe AI could make a bigger difference in other areas.
The available text does not name the startups or provide details about the alternative uses they favor. It also includes unrelated commentary about a YouTube parody, without further reporting on the biotech companies.
Sources: STAT News.